Topics
Gliomas | Treatment | Surgery | Resection extent
Home > Publications > Topics > Gliomas > Treatment > Surgery > Resection extent
2011
Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V.
Intraoperative MRI guidance and extent
of resection in glioma surgery: a randomised, controlled trial.
Lancet
Oncol. 2011 Aug 23;12(11):997-1003. doi:
10.1016/S1470-2045(11)70196-6. PMID:
21868284. Trial
registration ID: NCT01394692. ˍ
2024
Karschnia P, Gerritsen JKW, Teske N, Cahill DP, Jakola AS, van den
Bent M, Weller M, Schnell O, Vik-Mo EO, Thon N, Vincent AJPE, Kim
MM, Reifenberger G, Chang SM, Hervey-Jumper SL, Berger MS, Tonn
JC.
The oncological role of resection
in newly diagnosed diffuse adult-type glioma defined by the WHO
2021 classification: a Review by the RANO resect group.
Lancet
Oncol. 2024 Sep;25(9):e404-e419. doi:
10.1016/S1470-2045(24)00130-X. PMID:
39214112. Review. ˍ
2025
Mirzayeva LS, Uçar M, Budak SN, Kaymaz AM, Yaylı N.
Pushing the boundaries of
neurosurgical oncology: evaluating the superiority of supratotal
resection over gross total resection in intraoperative MRI-guided
glioma surgery.
Neurosurg
Rev. 2025 Feb 6;48(1):200. doi:
10.1007/s10143-025-03301-x. PMID:
39909935. Observational study. ˍ
Falcão L, Cerqueira GA, Gonçalves JPF, de Andrade
JFT, de Azevedo Figueiredo Trocoli CP, Medrado-Nunes GS, Santos
VEC, Pustilnik HN, Fontes JHM, Dos Passos GS.
Influence
of supratotal resection on overall survival and progression of
tumor in gliomas grade 2 and 3: a systematic review and
meta-analysis.
Neurosurg
Rev. 2025 Mar 4;48(1):281. doi:
10.1007/s10143-025-03428-x. PMID:
40032671. Review; Meta-analysis˰
ˍ
*Krucoff MO.
Surgical decision making
in the era of supramarginal glioma resections: a current
perspective and narrative review.
CNS
Oncol. 2025 Oct 28;14(1):2571341. doi:
10.1080/20450907.2025.2571341. PMID:
41147694. Perspective. ˍ